SCHEMBL4767747

SCHEMBL4767747

CCOC(=O)c1cc(-c2ccncc2)[nH]c1C(CNC(=O)OC(C)(C)C)Cc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCGR P47871 3/20 0.45
SYK P43405 1/20 0.41
CDC7 O00311 4/20 0.40
CDK5 Q00535 2/20 0.39
CDK5R1 Q15078 2/20 0.39
MAPK14 Q16539 1/20 0.39
ACACB O00763 1/20 0.38
ACACA Q13085 1/20 0.38
NPSR1 Q6W5P4 2/20 0.38
MAPK1 P28482 1/20 0.38
DBF4 Q9UBU7 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ATM Q13315 1/20 0.37
EPHX2 P34913 1/20 0.37
ALDH1A1 P00352 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4775802 0.86 GCGR (0.49) GCGRCDC7CDK5CDK5R1MAPK14
Hydrochloric Acid SCHEMBL4771889 0.83 GCGR (0.50) GCGRCDC7CDK5CDK5R1MAPK14
SCHEMBL4771352 0.81 ATM (0.46) GCGRSYKCDC7CDK5CDK5R1
SCHEMBL4767661 0.77 GCGR (0.46) GCGRCDC7CDK5CDK5R1MAPK14
SCHEMBL4768810 0.76 GCGR (0.51) GCGRCDC7CDK5CDK5R1MAPK14
SCHEMBL4767710 0.75 GCGR (0.49) GCGRCDC7CDK5CDK5R1MAPK14
SCHEMBL5346356 0.74 GCGR (0.53) GCGRCDC7CDK5CDK5R1MAPK14
SCHEMBL4774859 0.73 GCGR (0.48) GCGRCDC7CDK5CDK5R1MAPK14
Hydrochloric Acid SCHEMBL6466304 0.72 CDC7 (0.53) GCGRCDC7CDK5CDK5R1MAPK14
SCHEMBL4771823 0.71 GCGR (0.46) GCGRCDC7CDK5CDK5R1MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660085-B1 PYRIDYLPYRROLE DERIVATIVES ACTIVE AS KINASE INHIBITORS PFIZER ITALIA SRL (IT) 2008-10-15 EP disclosed
US-20050043346-A1 Pyridylpyrrole derivatives active as kinase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2005-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043346-A1 Pyridylpyrrole derivatives active as kinase inhibitors MAP3K6, MAP3K5, MAP4K2 GCGR 1852/4885SYK 585/4885CDC7 426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.